{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T17:10:25Z","timestamp":1795108225817,"version":"4.10.3"},"reference-count":46,"publisher":"BMJ","issue":"5","funder":[{"DOI":"10.13039\/100000066","name":"National Institute of Environmental Health Sciences","doi-asserted-by":"publisher","award":["5P42ES010337"],"award-info":[{"award-number":["5P42ES010337"]}],"id":[{"id":"10.13039\/100000066","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","award":["5UL1TR001442"],"award-info":[{"award-number":["5UL1TR001442"]}],"id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]},{"name":"U.S. Department of Defense, the Peer Reviewed Cancer Research Program","award":["W81XWH-18-2-0026"],"award-info":[{"award-number":["W81XWH-18-2-0026"]}],"id":[{"id":"https:\/\/ror.org\/0447fe631","id-type":"ROR","asserted-by":"crossref"}]},{"DOI":"10.13039\/100008732","name":"Uehara Memorial Foundation","doi-asserted-by":"publisher","award":["201940021"],"award-info":[{"award-number":["201940021"]}],"id":[{"id":"10.13039\/100008732","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000027","name":"National Institute on Alcohol Abuse and Alcoholism","doi-asserted-by":"publisher","award":["K23DK119460"],"award-info":[{"award-number":["K23DK119460"]}],"id":[{"id":"10.13039\/100000027","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000027","name":"National Institute on Alcohol Abuse and Alcoholism","doi-asserted-by":"publisher","award":["U01AA029019"],"award-info":[{"award-number":["U01AA029019"]}],"id":[{"id":"10.13039\/100000027","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["P01HL147835"],"award-info":[{"award-number":["P01HL147835"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["U01AA029019"],"award-info":[{"award-number":["U01AA029019"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["K23DK119460"],"award-info":[{"award-number":["K23DK119460"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["P30DK120515"],"award-info":[{"award-number":["P30DK120515"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["R01DK106419"],"award-info":[{"award-number":["R01DK106419"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["R01DK121378"],"award-info":[{"award-number":["R01DK121378"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["R01DK124318"],"award-info":[{"award-number":["R01DK124318"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["U01DK061734"],"award-info":[{"award-number":["U01DK061734"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Gut"],"accepted":{"date-parts":[[2021,4,8]]},"published-print":{"date-parts":[[2022,5]]},"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>Emerging data suggest that a 30% relative decline in liver fat, as assessed by MRI-proton density fat fraction (MRI-PDFF), may be associated with Non-Alcoholic Fatty Liver Disease Activity Score improvement, but the association between decline in MRI-PDFF and fibrosis regression is not known. Therefore, we aimed to examine the association between \u226530% relative decline in MRI-PDFF and fibrosis regression in non-alcoholic fatty liver disease (NAFLD).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design<\/jats:title>\n                    <jats:p>\n                      This prospective study included 100 well-characterised patients with biopsy-proven NAFLD with paired contemporaneous MRI-PDFF assessment at two time points. MRI-PDFF response was defined as \u226530% relative decline in MRI-PDFF. The\n                      <jats:italic>primary outcome<\/jats:italic>\n                      was \u22651 stage histological fibrosis regression.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      The median (IQR) age was 54 (43\u201362) years and body mass index was 31.9 (29\u201336)\u2009kg\/m\n                      <jats:sup>2<\/jats:sup>\n                      . In multivariable-adjusted logistic regression analysis (adjusted for age, gender, diabetes status, race\/ethnicity, interval between biopsies, gamma-glutamyl transferase, liver stiffness by magnetic resonance elastography and change in platelet counts), MRI-PDFF response was an independent predictor of fibrosis regression with an adjusted OR of 6.46 (95% CI 1.1 to 37.0, p=0.04). The proportion of patients with MRI-PDFF response with fibrosis regression, no change in fibrosis and fibrosis progression was 40.0%, 24.6% and 13.0%, respectively, and the proportion of patients with MRI-PDFF response increased with fibrosis regression (p=0.03).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>\u226530% reduction in MRI-PDFF in early phase trials can provide a useful estimate of odds of \u22651 stage improvement in fibrosis. These data may be helpful in sample size estimation in non-alcoholic steatohepatitis trials.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/gutjnl-2021-324264","type":"journal-article","created":{"date-parts":[[2021,4,21]],"date-time":"2021-04-21T13:30:13Z","timestamp":1619011813000},"page":"983-990","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":121,"title":["Clinical utility of 30% relative decline in MRI-PDFF in predicting fibrosis regression in non-alcoholic fatty liver disease"],"prefix":"10.1136","volume":"71","author":[{"given":"Nobuharu","family":"Tamaki","sequence":"first","affiliation":[{"name":"NAFLD Research Center, Department of Medicine, University of California San Diego, La Jolla, California, USA"},{"name":"Department of Gastroenterology and Hepatology, Musashino Red Cross Hospital, Musashino, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nagambika","family":"Munaganuru","sequence":"additional","affiliation":[{"name":"NAFLD Research Center, Department of Medicine, University of California San Diego, La Jolla, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9786-5507","authenticated-orcid":false,"given":"Jinho","family":"Jung","sequence":"additional","affiliation":[{"name":"NAFLD Research Center, Department of Medicine, University of California San Diego, La Jolla, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aed Qas","family":"Yonan","sequence":"additional","affiliation":[{"name":"NAFLD Research Center, Department of Medicine, University of California San Diego, La Jolla, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rohan R","family":"Loomba","sequence":"additional","affiliation":[{"name":"NAFLD Research Center, Department of Medicine, University of California San Diego, La Jolla, California, USA"},{"name":"Cathedral Catholic High School, San Diego, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richele","family":"Bettencourt","sequence":"additional","affiliation":[{"name":"NAFLD Research Center, Department of Medicine, University of California San Diego, La Jolla, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veeral","family":"Ajmera","sequence":"additional","affiliation":[{"name":"NAFLD Research Center, Department of Medicine, University of California San Diego, La Jolla, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark A","family":"Valasek","sequence":"additional","affiliation":[{"name":"Department of Pathology, University of California San Diego, La Jolla, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cynthia","family":"Behling","sequence":"additional","affiliation":[{"name":"Department of Pathology, University of California San Diego, La Jolla, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claude B","family":"Sirlin","sequence":"additional","affiliation":[{"name":"Liver Imaging Group, Department of Radiology, University of California San Diego, La Jolla, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4845-9991","authenticated-orcid":false,"given":"Rohit","family":"Loomba","sequence":"additional","affiliation":[{"name":"NAFLD Research Center, Department of Medicine, University of California San Diego, La Jolla, California, USA"},{"name":"Department of Family Medicine and Public Health, University of California San Diego, La Jolla, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2021,4,21]]},"reference":[{"key":"2025090800373110000_71.5.983.1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2018.10.033"},{"key":"2025090800373110000_71.5.983.2","doi-asserted-by":"publisher","DOI":"10.1038\/nrgastro.2013.171"},{"key":"2025090800373110000_71.5.983.3","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/S2468-1253(19)30039-1","article-title":"Prevalence, incidence, and outcome of non-alcoholic fatty liver disease in Asia, 1999-2019: a systematic review and meta-analysis","volume":"4","author":"Li","year":"2019","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"2025090800373110000_71.5.983.4","doi-asserted-by":"publisher","DOI":"10.1002\/hep.29085"},{"key":"2025090800373110000_71.5.983.5","doi-asserted-by":"publisher","DOI":"10.1002\/hep.27368"},{"key":"2025090800373110000_71.5.983.6","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2017.07.027"},{"key":"2025090800373110000_71.5.983.7","doi-asserted-by":"publisher","DOI":"10.1002\/hep.20701"},{"key":"2025090800373110000_71.5.983.8","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2002.06038.x"},{"key":"2025090800373110000_71.5.983.9","doi-asserted-by":"publisher","DOI":"10.1002\/jgh3.12289"},{"key":"2025090800373110000_71.5.983.10","doi-asserted-by":"crossref","first-page":"30399","DOI":"10.1016\/j.jhep.2020.06.025","article-title":"Suboptimal reliability of liver biopsy evaluation has implications for randomized clinical trials","volume":"73","author":"Davison","year":"2020","journal-title":"J Hepatol"},{"key":"2025090800373110000_71.5.983.11","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2012.05121.x"},{"key":"2025090800373110000_71.5.983.12","doi-asserted-by":"publisher","DOI":"10.1002\/hep.29797"},{"key":"2025090800373110000_71.5.983.13","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2015.11.048"},{"key":"2025090800373110000_71.5.983.14","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2016.10.026"},{"key":"2025090800373110000_71.5.983.15","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2018.12.036"},{"key":"2025090800373110000_71.5.983.16","doi-asserted-by":"publisher","DOI":"10.1002\/hep.26455"},{"key":"2025090800373110000_71.5.983.17","doi-asserted-by":"publisher","DOI":"10.1002\/hep.25731"},{"key":"2025090800373110000_71.5.983.18","doi-asserted-by":"publisher","DOI":"10.1002\/hep.27647"},{"key":"2025090800373110000_71.5.983.19","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/S2468-1253(20)30186-2","article-title":"Novel antisense inhibition of diacylglycerol O-acyltransferase 2 for treatment of non-alcoholic fatty liver disease: a multicentre, double-blind, randomised, placebo-controlled phase 2 trial","volume":"5","author":"Loomba","year":"2020","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"2025090800373110000_71.5.983.20","doi-asserted-by":"crossref","unstructured":"Loomba R . MRI-PDFF treatment response criteria in nonalcoholic steatohepatitis. Hepatology 2020.","DOI":"10.1002\/hep.31624"},{"key":"2025090800373110000_71.5.983.21","doi-asserted-by":"publisher","DOI":"10.1002\/hep.29514"},{"key":"2025090800373110000_71.5.983.22","doi-asserted-by":"publisher","DOI":"10.1002\/hep.31121"},{"key":"2025090800373110000_71.5.983.23","doi-asserted-by":"publisher","DOI":"10.1177\/1756283X16656735"},{"key":"2025090800373110000_71.5.983.24","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2018.09.024"},{"key":"2025090800373110000_71.5.983.25","first-page":"31220","article-title":"Change in MRI-PDFF and histologic response in patients with nonalcoholic steatohepatitis: a systematic review and meta-analysis","volume":"31","author":"Stine","year":"2020","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2025090800373110000_71.5.983.26","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.14140754"},{"key":"2025090800373110000_71.5.983.27","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.12120896"},{"key":"2025090800373110000_71.5.983.28","doi-asserted-by":"publisher","DOI":"10.1172\/JCI93465"},{"key":"2025090800373110000_71.5.983.29","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2014.04.014"},{"key":"2025090800373110000_71.5.983.30","doi-asserted-by":"publisher","DOI":"10.1038\/bmt.2012.244"},{"key":"2025090800373110000_71.5.983.31","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2016.04.021"},{"key":"2025090800373110000_71.5.983.32","doi-asserted-by":"publisher","DOI":"10.1002\/hep.31108"},{"key":"2025090800373110000_71.5.983.33","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(19)33041-7"},{"key":"2025090800373110000_71.5.983.34","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2014.04.038"},{"key":"2025090800373110000_71.5.983.35","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(14)61933-4"},{"key":"2025090800373110000_71.5.983.36","doi-asserted-by":"publisher","DOI":"10.1002\/hep.29477"},{"key":"2025090800373110000_71.5.983.37","doi-asserted-by":"publisher","DOI":"10.1111\/hepr.13179"},{"key":"2025090800373110000_71.5.983.38","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0221548"},{"key":"2025090800373110000_71.5.983.39","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.2020191160"},{"key":"2025090800373110000_71.5.983.40","doi-asserted-by":"publisher","DOI":"10.1002\/hep.29596"},{"key":"2025090800373110000_71.5.983.41","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2017.06.005"},{"key":"2025090800373110000_71.5.983.42","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2019.12565","article-title":"Association of histologic disease activity with progression of nonalcoholic fatty liver disease","volume":"2","author":"Kleiner","year":"2019","journal-title":"JAMA Netw Open"},{"key":"2025090800373110000_71.5.983.43","article-title":"Clinical utility of change in nonalcoholic fatty liver disease activity score and change in fibrosis in NAFLD","author":"Tamaki","year":"2020","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2025090800373110000_71.5.983.44","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2020-322976"},{"key":"2025090800373110000_71.5.983.45","doi-asserted-by":"publisher","DOI":"10.1111\/hepr.13286"},{"key":"2025090800373110000_71.5.983.46","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2016.00491","article-title":"Elastin in the liver","volume":"7","author":"Kanta","year":"2016","journal-title":"Front Physiol"}],"container-title":["Gut"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/gutjnl-2021-324264","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T07:37:39Z","timestamp":1757317059000},"score":1,"resource":{"primary":{"URL":"https:\/\/gut.bmj.com\/lookup\/doi\/10.1136\/gutjnl-2021-324264"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,21]]},"references-count":46,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2022,4,8]]},"published-print":{"date-parts":[[2022,5]]}},"alternative-id":["10.1136\/gutjnl-2021-324264"],"URL":"https:\/\/doi.org\/10.1136\/gutjnl-2021-324264","relation":{},"ISSN":["0017-5749","1468-3288"],"issn-type":[{"value":"0017-5749","type":"print"},{"value":"1468-3288","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4,21]]}}}